Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-02-03 @ 7:21 AM
Study NCT ID:
NCT01551459
Status:
COMPLETED
Last Update Posted:
2019-10-29
First Post:
2012-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma
Sponsor:
The Clatterbridge Cancer Centre NHS Foundation Trust
Organization: